People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Luna Pharmaceuticals, Inc. | — | Biotech / Pharma | Series A | $10.5M | $148.8M | 2016 |
Ray Mathieu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ray Mathieu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Murphy | 1 | 9 |
| Amy Wolf | 1 | 6 |
| Peter Finn | 1 | 5 |
| KEVIN M MURPHY | 1 | 3 |
| Charlie Baynes-Reid | 1 | 2 |
| Dan Aziz | 1 | 1 |
| Raymond M. Mathieu | 1 | 1 |
| Mark M. Lerohl | 1 | 1 |
| Amy M. Wolf | 1 | 1 |
| Richard M. Katzman | 1 | 1 |
| Mark Lehrol | 1 | 1 |
| Anthony Longo | 1 | 1 |
| Amy D. Wolf | 1 | 1 |
| Arlene D. Dickinson | 1 | 1 |
| Raymond D. Mathieu | 1 | 1 |
| Robert D. Aziz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.